Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001091818-21-000016
Filing Date
2021-02-16
Accepted
2021-02-16 09:08:11
Documents
37
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 YEAR END REPORT DEC. 31, 2020 bfnh01222021form10kdec2020.htm 10-K 212942
2 CERTIFICATION ex311.htm EX-31.1 4856
3 CERTIFICATION ex312.htm EX-31.2 4936
4 CERTIFICATION ex321.htm EX-32.1 2130
5 CERTIFICATION ex322.htm EX-32.2 2160
12 a0101450current001.jpg GRAPHIC 21193
13 a0101450current002.jpg GRAPHIC 14139
14 a0101450current003.jpg GRAPHIC 200486
  Complete submission text file 0001091818-21-000016.txt   1374587

Data Files

Seq Description Document Type Size
6 bfnh-20201231.xml EX-101.INS 72197
7 bfnh-20201231.xsd EX-101.SCH 16500
8 bfnh-20201231_cal.xml EX-101.CAL 26087
9 bfnh-20201231_def.xml EX-101.DEF 35997
10 bfnh-20201231_lab.xml EX-101.LAB 120215
11 bfnh-20201231_pre.xml EX-101.PRE 91414
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51074 | Film No.: 21633148
SIC: 3826 Laboratory Analytical Instruments